Bioanalytical Services Market to Reach Valuation of US$ 12.34 Bn by 2031 Propelled by Rising Adoption in Various Drug Development Stages: TMR Study

-  Substantial demand for small molecular and large molecular bioanalytical services among pharma & biotechnology companies to generate sizable revenue streams

-  Providers offering immunochemistry services to tap into massive lucrative streams in ongoing clinical trials; North America and Asia Pacific expected to be potentially lucrative markets

ALBANY, N.Y., Jan. 10, 2022 /PRNewswire/ -- Transparency Market Research: The array of bioanalytical services has enormously expanded for various stages of drug development life cycles, pharmaceuticals, biopharmaceuticals, vaccines, and biosimilars. The demand for bioanalytical services to support clinical development and regulatory filing has risen across pharmaceutical and biotech companies. The global bioanalytical services market is projected to advance at CAGR of 8.2% during the forecast period (2021–2031).

Service providers have reaped lucrative revenue gains from the widespread uptake of immunochemistry services. In recent months, the demand for bioanalytical services for the development of drugs and vaccines for COVID-19 infection has accelerated the growth prospects of the bioanalytical services market.

End users are benefitting from cutting-edge research and development (R&D) experience for regulatory and non-regulatory guidelines and standardizations for immunological assay testing. Moreover, the growing demand for large molecule bioanalysis for biologic drugs and biomarker analysis is propelling the revenue prospects.

Leading players in the bioanalytical services market are keenly expanding their network of experts to meet the needs of elemental bioanalysis and biosimilar analysis among end users. Service providers are leaning on understanding, estimating, and resolving the complexities of quantitative immunoassays and challenges in pre-clinical testing methods.

Request Brochure of Bioanalytical Services Market Research Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=47676

Key Findings of Bioanalytical Services Market Study  

• Small Molecule Bioanalytical Services Present Vast Avenue: The demand for bioanalytical services in both large molecule and small molecule drug candidates has grown over the years. The TMR study on the bioanalytical services market finds that small molecule analysis held a leading share in 2020, given the substantial demand for immunoassays, cell-based neutralization assays, and LCMS method development in small molecule bioanalysis.
• Focus of Pharmaceuticals on Contract Research Organizations (CRO) to Spur Growth Prospects: The trend of pharmaceutical companies for outsourcing drug development activities has gained pace. The trend is evident in oncology, finds TMR analysts evaluating the revenue prospects of the bioanalytical services market. CROs are harnessing state-of-the-art AI methods for Big Data analytics. Pharma & biotechnology companies are expected to present sizable sales opportunities.

Request for Analysis of COVID-19 Impact on Bioanalytical Services Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=47676

• Rise in Demand for Immunochemistry Services to Offer Massive Revenue Growth: Over the years, immunochemistry services are gaining traction for immunoassay development, especially for supporting pharmacokinetic and toxicokinetic studies. The segment held a higher share than that of any other service, and is projected to retain the lead during the forecast period, find TMR analysts in the study on the bioanalytical services market.

Bioanalytical Services Market: Key Drivers

• The prevalence and healthcare burden of infectious diseases has spurred the need for bioanalysis in drug development in clinical and pre-clinical studies, finds the TMR study scrutinizing the growth dynamics of the global bioanalytical services market. For instance, leading-edge bioanalytical diagnostic technologies have significantly mitigated the mortality and morbidity of COVID-19 pandemic. Most important, this is anticipated to play crucial role in infectious disease outbreaks in near future.
• Advancements in bioanalysis methods for novel therapeutics in ongoing clinical trials globally have extended the horizon for players in the bioanalytical services market

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough, Request for Custom Research -       

https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=47676

Bioanalytical Services Market: Regional Growth Dynamics

• North America is anticipated to hold a major share of the global bioanalytical services market during the forecast period. Demand for advanced bioanalysis methods for novel therapeutics and substantial investments in clinical trials are propelling the growth of the regional market. The U.S. held a leading share of the North America market in 2020.
• The opportunities in the Asia Pacific bioanalytical services market are projected to rise at prominent growth rate in the next few years. Rise in demand for bioanalytical services among contract research organizations, especially in China, India, and Japan, has spurred the revenue prospects.

Buy Bioanalytical Services Market Research Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=47676&ltype=S

Bioanalytical Services Market: Key Players

Some of the prominent companies in the bioanalytical services market are:

• IQVIA
• Eurofins Scientific
• WuXi AppTec
• PRA Health Sciences
• Medpace
• Pace Analytical Services
• Intertek Group
• SGS SA Toxikon, Inc.
• Syneos Health
• Charles River Laboratories International, Inc.
• Laboratory Corporation of America
• ICON plc.
• PPD, Inc.

Global Bioanalytical Services Market: Segmentation

Bioanalytical Services Market, by Service

• Immunochemistry Services
• Quantitative Immunoassays
• Cell-based Neutralization Assays
• LCMS Method Development
• Discovery Phase Bioanalysis
• LCMS Sample Bioanalysis
• GCP Bioanalysis Service
• Biomarker Assays
• Protein Analysis
• Others

Bioanalytical Services Market, by Type

• Small Molecule Bioanalysis
• Large Molecule Bioanalysis
• Others

Bioanalytical Services Market, by End-user

• Pharma & Biotechnology Companies
• Contract Research Organizations
• Others

Bioanalytical Services Market, by Region

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Italy
• Spain
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Industry Research Reports by Transparency Market Research:

Healthcare Informatics and Patient Monitoring Market: Rise in prevalence of chronic disorders and increasing adoption of state of the art technologies in the healthcare systems are some of the key factors driving the growth of the global healthcare informatics and patient monitoring market.

Biosimilars Market: Companies in the biosimilars market are tapping into opportunities in orphan biosimilars. Biosimilars are gaining popularity as affordable treatment options for patients in need of biologics. Due to the high prevalence of rare diseases, companies have a renewed purpose to steer innovation in biosimilars. Thus, manufacturers are increasing efforts to fulfill unmet needs of patients with rare diseases by increasing the availability of low-cost biosimilars.

Hepatitis E Diagnostic Tests Market: The global hepatitis e diagnostic tests market is being propelled by rising public awareness about the need of early HEV detection. IgG titers in the sample set imply that the person has been infected with HEV earlier. According to the WHO, there are over 20.1 million instances of infection globally, with over 3.3 million of them being symptomatic, resulting in over 70,000 fatalities and 3,000 stillbirths.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Follow Us: Twitter | LinkedIn
Blog: https://tmrblog.com
Browse PR - https://www.transparencymarketresearch.com/pressrelease/bioanalytical-services-market.htm

Logo: https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg